RESOLUTION BIOSCIENCE, INC.
KIRKLAND, WA

Patients are why we are here. We have all been touched by cancer. Helping patients drives us to make the best diagnostics available. Clinicians stand at the frontline of care. As the director of patient care, we work with them to provide critical information. COMPANY The Resolution Bioscience ctDx platform has been validated to detect all four kinds of mutations. Other assays may only detect SNVs or small indels. Unfortunately, a cancer can progress with other types of mutations such as gene amplification. If your diagnostic test cannot detect all four kinds of mutations, then you may miss critical information required to make the proper clinical decision. We have all been touched by cancer. We believe that more can be done to help patients. We contribute by developing better tools for clinicians and researchers to aid them in their fight against this disease. Resolution Bioscience, Inc. is a privately-held next generation sequencing (NGS) technology company. The company was founded in 2012 and is based in Bellevue, Washington. NGS is similar to the internet of the early 1990s — an incredible information tool that has yet to reach its fullest impact. We want to help bring the power of NGS to help patients around the world. We believe that we will look back in 10 years and wonder "how did we live without it?" Patients are why we are here. We have all been touched by cancer. Helping patients drives us to make the best diagnostics available. Clinicians stand at the frontline of care. As the director of patient care, we work with them to provide critical information. COMPANY